GLYPHIC BIOTECHNOLOGIES, INC.

NEW YORK, NEW YORK 100165101

Minority Owned
$250K
Total Contract Value
1 awards
First Award
Apr 8, 2024
Last Award
Apr 8, 2024
Business Size
small
CAGE Code
94M19

Top Industries (NAICS)

NAICS CodeObligationsAwards
541715$250K1

Contract Awards

1 awards found

HT942524P0042
Department of Defense
$250K
Apr 8, 2024

MEDICAL R AND D PURCHASE ORDER FOR A DHA STTR PHASE I, PROPOSAL NO. H23C-001-0042, TITLED, "DEVELOPMENT OF ANTI-GLYCAN ANTIBODIES AGAINST MULTI-DRUG RESISTANT ESKAPE WOUND PATHOGENS"

NAICS: 541715 - RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)FY2024

Business Details

UEI
F57WT7JZDH19
CAGE Code
94M19
Address
169 MADISON AVE
STE 2216
NEW YORK, NY 100165101
Congressional District
NY-12

Parent Company

GLYPHIC BIOTECHNOLOGIES, INC.

Data Source

This profile is based on federal contract award data from USAspending.gov.

View on USAspending.gov